Natasha Monkman Responds to the Question, “What Are The Legal Risks of Offering Ozempic As An Employee Benefit?” in Canadian HR Reporter

In this article that addresses the legal implications of weight loss drug exclusions from employee benefits plans as employers look to cut costs, Natasha Monkman warns employers that excluding the drugs may result in claims of discrimination. “There are risks of targeting drugs for exclusion, because if that drug is treating a particular type of condition, then there’s risk of a claim from somebody who is affected by that condition,” Natasha explains. Conversely, Natasha mentions the considerable return on investment employers can realize if they effectively consider wellness programs in conjunction with their benefit coverage.

Read more about Natasha’s insights and advice in the full article.